Stillwater Mining Company to Participate in the Goldman Sachs Global Metals and Mining Conference
Nov 02, 2016 12:00 pm UTC| Business
LITTLETON, Colo., Nov. 02, 2016 -- Stillwater Mining Company (NYSE:SWC) announced today that Mick McMullen, the Company’s President and Chief Executive Officer will participate in the Goldman Sachs Annual Metals and...
Yeast Market Globally to reach USD4.86 Billion by 2021, according to Zion Market Research
Nov 02, 2016 12:00 pm UTC| Business
Sarasota, FL, Nov. 02, 2016 -- Zion Research has published a new report titled “Yeast Market by Form (Instant, Fresh and Dry Yeast), by Type (Brewers, Bakers, Bio-ethanol, Wine, Feed and Other type), by Specialty Yeast...
LivaNova Reports Third Quarter 2016 Results
Nov 02, 2016 11:46 am UTC| Business
LONDON, Nov. 02, 2016 -- LivaNova PLC (NASDAQ:LIVN)(LSE:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today reported results for the third quarter ended September 30,...
Neuralstem Announces Presentations at Upcoming Scientific Conferences
Nov 02, 2016 11:35 am UTC| Business
GERMANTOWN, Md., Nov. 02, 2016 -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of central nervous system therapies based on its neural stem cell technology, announced poster...
Affimed Reports Financial Results for Third Quarter 2016
Nov 02, 2016 11:34 am UTC| Business
Heidelberg, Germany, Nov. 02, 2016 -- Heidelberg, Germany, November 2, 2016 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer...
Nov 02, 2016 11:31 am UTC| Business
New survey reveals children’s and education philanthropy top listsReport finds that Chinese Americans and likely other immigrants are deeply invested in communitiesWealthy non-Chinese are more likely to donate to religious...
Affimed Reports Financial Results for Third Quarter 2016
Nov 02, 2016 11:31 am UTC| Business
HEIDELBERG, Germany, Nov. 02, 2016 -- Affimed N.V. (Nasdaq:AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today reported financial results...